Overview

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

Status:
Not yet recruiting

Trial end date:
2024-07-15

Target enrollment:

Participant gender:

Summary

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Shanghai Henlius Biotech

Collaborators:

HeNan Sincere Biotech Co., Ltd
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.